![Nicotinamide for the treatment of heart failure with preserved ejection fraction | Science Translational Medicine Nicotinamide for the treatment of heart failure with preserved ejection fraction | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd7064/asset/48edd895-4df0-4793-b1aa-e0d1ef51b057/assets/graphic/abd7064-f1.jpeg)
Nicotinamide for the treatment of heart failure with preserved ejection fraction | Science Translational Medicine
![IJMS | Free Full-Text | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming IJMS | Free Full-Text | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming](https://pub.mdpi-res.com/ijms/ijms-22-05887/article_deploy/html/images/ijms-22-05887-g001-550.jpg?1622421506)
IJMS | Free Full-Text | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
![Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment | Cancer Gene Therapy Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment | Cancer Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41417-021-00354-0/MediaObjects/41417_2021_354_Fig1_HTML.png)